These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6869037

  • 1. Interactions of a partial ergoline with dopamine receptors in vivo and in vitro.
    Fuxe K, Goldstein M, Agnati LF, Köhler C, Lew JY, Okada K.
    Acta Physiol Scand; 1983 Feb; 117(2):303-5. PubMed ID: 6869037
    [No Abstract] [Full Text] [Related]

  • 2. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR, Weinberger S, Segal DS, Creese I.
    Experientia; 1982 Oct 15; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract] [Full Text] [Related]

  • 3. Selective modulation of 3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the rat.
    Agnati LF, Benfenati F, Battistini N, Cavicchioli L, Fuxe K, Toffano G.
    Acta Physiol Scand; 1983 Feb 15; 117(2):311-4. PubMed ID: 6869038
    [No Abstract] [Full Text] [Related]

  • 4. Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes.
    Agnati LF, Fuxe K, Battistini N, Benfenati F.
    Acta Physiol Scand; 1984 Mar 15; 120(3):465-7. PubMed ID: 6331074
    [No Abstract] [Full Text] [Related]

  • 5. Occupation of dopamine receptors by N-n-propylnorapomorphine or spiperone and acetylcholine levels in the rat striatum.
    Korf J, Sebens JB, Flentge F, van der Werf JF.
    J Neurochem; 1985 Jan 15; 44(1):314-8. PubMed ID: 3964835
    [Abstract] [Full Text] [Related]

  • 6. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites.
    Agnati LF, Celani MF, Fuxe K.
    Acta Physiol Scand; 1983 May 15; 118(1):79-81. PubMed ID: 6312748
    [No Abstract] [Full Text] [Related]

  • 7. Chronic dihydroergotoxine treatment affects the number of dopamine recognition sites in rat striatum.
    Battaini F, Govoni S, Rius RA, Spano PF, Trabucchi M.
    Pharmacol Res Commun; 1984 Jun 15; 16(6):605-11. PubMed ID: 6463097
    [Abstract] [Full Text] [Related]

  • 8. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S, Robson PA.
    Neuropharmacology; 1981 Dec 15; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract] [Full Text] [Related]

  • 9. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL, Krstich M, Beart PM.
    Brain Res; 1983 Nov 14; 278(1-2):155-63. PubMed ID: 6227373
    [Abstract] [Full Text] [Related]

  • 10. Striatal dopamine receptor function in morphine-tolerant dependent rats: influence of hypothalamic peptides.
    Bhargava HN.
    NIDA Res Monogr; 1984 Mar 14; 49():320-6. PubMed ID: 6148693
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. On the mechanism of mergocryptine-induced suppression of dopamine turnover in the rat striatum.
    Hashimoto T, Katsura M, Kuriyama K.
    Eur J Pharmacol; 1991 Jun 06; 198(2-3):121-7. PubMed ID: 1864302
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE, Gommeren W.
    J Neurochem; 1981 Jan 06; 36(1):201-19. PubMed ID: 7463046
    [Abstract] [Full Text] [Related]

  • 16. Lisuride inhibits 3H-spiroperidol binding to membranes isolated from striatum.
    Fujita N, Saito K, Yonehara N, Yoshida H.
    Neuropharmacology; 1978 Dec 06; 17(12):1089-91. PubMed ID: 745698
    [No Abstract] [Full Text] [Related]

  • 17. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
    Bhargava HN.
    Gen Pharmacol; 1983 Dec 06; 14(6):609-14. PubMed ID: 6141122
    [Abstract] [Full Text] [Related]

  • 18. A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
    Martin GE, Williams M, Haubrich DR.
    J Pharmacol Exp Ther; 1982 Nov 06; 223(2):298-304. PubMed ID: 6813451
    [No Abstract] [Full Text] [Related]

  • 19. Study on some compensatory responses of dopaminergic system in aging rats.
    Algeri S, Achilli G, Cimino M, Perego C, Ponzio F, Vantini G.
    Exp Brain Res; 1982 Nov 06; Suppl 5():146-52. PubMed ID: 7151906
    [No Abstract] [Full Text] [Related]

  • 20. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA, Marsh CL.
    Mol Pharmacol; 1984 Nov 06; 26(3):439-51. PubMed ID: 6238230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.